US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bayer A.G.

13.60

-0.0300-0.22%

Volume:738.85K

Turnover:10.05M

Market Cap:53.44B

PE:-21.49

High:13.67

Open:13.52

Low:13.49

Close:13.63

52wk High:15.23

52wk Low:7.19

Shares:3.93B

Float Shares:3.93B

Volume Ratio:0.94

T/O Rate:0.02%

Dividend:0.03

Dividend Rate:0.23%

EPS(TTM):-0.6327

EPS(LYR):-0.6723

ROE:-6.93%

ROA:3.64%

PB:1.62

PE(LYR):-20.23

Loading ...

Overview Company News Filings

Bayer announces leadership changes within Consumer Health division

Bayer Targets Atrial Fibrillation With New Phase 2 Rhythm Drug: What Investors Should Watch

Bayer Hit by New Roundup Legal Jitters -- Market Talk

Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement

Bayer's Key Pharma Products Face Competitive Risk -- Market Talk

Bayer Can Still Take Hit If Litigation Strategy Fails -- Market Talk

Bayer to present new data across oncology portfolio

Bayer announces Priority Review designation for Kerendia

Bayer granted priority review for asundexian by FDA

Bayer launches 2026 campaign to expand food access with Luke Bryan

Dow Jones Top Company Headlines at 9 AM ET: EBay Rejects GameStop's $56 Billion Takeover Proposal | Under ...

Stocks to Watch: GameStop, Venture Global, Wendy's, Hims & Hers -- WSJ

Bayer Shares Climb After Earnings Beat Expectations

Stocks to Watch: Venture Global, Hims & Hers, GoPro -- WSJ

European Indexes Drop as Middle East Tensions Look Set to Continue -- Market Talk

Bayer Q1 Adj. EPS $0.79 Beats $0.64 Estimate, Sales $15.697B Beat $15.490B Estimate

Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion -- Update

Deals of the day-Mergers and acquisitions

Earning Preview: Bayer A.G. this quarter’s revenue is expected to increase by 1.68%, and institutional views are mixed with a cautious tilt

Bayer upgraded to Buy from Neutral at Rothschild & Co Redburn

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BAYRY/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BAYRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","market":"US","secType":"STK","nameCN":"Bayer A.G.","latestPrice":13.6,"timestamp":1784232000000,"preClose":13.63,"halted":0,"volume":738853,"delay":15,"changeRate":-0.0022010271460015506,"floatShares":3929259738,"shares":3929696328,"eps":-0.632721,"marketStatus":"Closed","change":-0.03,"latestTime":"07-16 16:00:00 EDT Delay","open":13.52,"high":13.67,"low":13.49,"amount":10047597.103400003,"amplitude":0.013206,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.632721,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784275200000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"OTCQX","adjPreClose":13.63,"volumeRatio":0.944563},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","floatShares":3929259738,"roa":"3.64%","roe":"-6.93%","lyrEps":-0.672343,"volumeRatio":0.944563,"shares":3929696328,"dividePrice":0.031466,"high":13.67,"amplitude":0.013206,"preClose":13.63,"low":13.49,"week52Low":7.19,"pbRate":"1.62","psRate":"1.03","week52High":15.23,"institutionHeld":0.0017,"latestPrice":13.6,"eps":-0.632721,"divideRate":0.002314,"volume":738853,"delay":15,"ttmEps":-0.632721,"open":13.52,"prevYearClose":10.82,"prevWeekClose":14.28,"prevMonthClose":13.7,"prevQuarterClose":13.7,"fiveDayClose":14.44,"twentyDayClose":10.38,"sixtyDayClose":12.12,"earningDate":1785772800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BAYRY\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"BAYRY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785830400000,"name":null,"time":"","dateTimestamp":1785816000000,"actualEps":null},{"market":"US","date":"2026-05-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"","actualEps":null},{"date":"2026-04-28","symbol":"BAYRY","amount":0.031526,"announcedDate":"2026-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-05-11"},{"market":"US","date":"2025-05-13","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"","actualEps":null},{"date":"2025-04-29","symbol":"BAYRY","amount":0.030365,"announcedDate":"2025-04-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-29","defaultRemindTime":1745933400000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-04-29","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-05-12"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BAYRY\",market:\"US\",,,undefined,":[{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-05-13","value":0.550569,"currency":"USD"},{"executeDate":"2020-04-29","recordDate":"2020-04-30","paymentDate":"2020-05-14","value":0.535933,"currency":"USD"},{"executeDate":"2021-04-28","recordDate":"2021-04-29","paymentDate":"2021-05-10","value":0.407111,"currency":"USD"},{"executeDate":"2022-05-02","recordDate":"2022-05-03","paymentDate":"2022-05-16","value":0.549114,"currency":"USD"},{"executeDate":"2023-05-02","recordDate":"2023-05-03","paymentDate":"2023-05-15","value":0.6318,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BAYRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1784001600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BAYRY\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641481010","title":"Bayer announces leadership changes within Consumer Health division","url":"https://stock-news.laohu8.com/highlight/detail?id=2641481010","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641481010?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:13","pubTimestamp":1780920822,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced leadership changes within its Consumer Health division. Key leadership appointments include: Samantha Avivi appointed globa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-announces-leadership-changes-within-consumer-health-division-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-announces-leadership-changes-within-consumer-health-division-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169683","title":"Bayer Targets Atrial Fibrillation With New Phase 2 Rhythm Drug: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169683","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169683?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:32","pubTimestamp":1780590747,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer A.G. (BAYRY) is launching a Phase 2 trial of BAY 3670549 in adults wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayer-targets-atrial-fibrillation-with-new-phase-2-rhythm-drug-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayer-targets-atrial-fibrillation-with-new-phase-2-rhythm-drug-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BAYRY","BK4007","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917455","title":"Bayer Hit by New Roundup Legal Jitters -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917455","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917455?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:22","pubTimestamp":1780399320,"startTime":"0","endTime":"0","summary":"1122 GMT - Bayer is dealing with jitters over its proposed Roundup settlement amid a potential shift of the class action to a federal court, Bank of America analysts say in a research note. The panel of judges who control and have power over multidistrict litigation transferred the class action to the Northern California federal court under Judge Vince Chhabria, who has been negative on the settlement in a recent hearing and rejected Bayer's attempt to settle the Roundup litigation in 2020, the analysts say. There is some debate on the validity of the decision, which the German group plans to oppose, and it is unclear how timelines evolve from here, they add. Investors might debate whether the settlement still holds, according to Bank of America. Shares in Bayer fall 5%. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350171.SGD","LU0098860793.USD","IE00BKVL7J92.USD","LU0320765489.SGD","LU0683600562.USD","LU1035773651.USD","IE00B1BXHZ80.USD","IE00BLSP4239.USD","LU1280957306.USD","LU1506573853.SGD","BK4007","LU0306807586.USD","LU0130102774.USD","BK4585","IE00BZ1G4Q59.USD","LU0234572021.USD","LU0203345920.USD","LU1162221912.USD","LU1201861249.SGD","BK4581","LU0149725797.USD","LU1363072403.SGD","LU2129689605.HKD","IE00BBT3K403.USD","LU0321505439.SGD","LU1069347547.HKD","LU1894683348.USD","BK4534","IE0001KFT4U8.USD","LU0980610538.SGD","LU0868494617.USD","LU0971096721.USD","LU0130518102.USD","BAC","LU0314106906.USD","LU0321505868.SGD","LU0477156953.USD","LU1880398554.USD","LU1201861165.SGD","LU0256863811.USD","LU1366192091.USD","LU0306806265.USD","LU0053666078.USD","LU0208291251.USD","BK4559","LU0310800965.SGD","BAYRY","LU0106831901.USD","LU0130517989.USD","LU2129689431.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917344","title":"Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917344","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917344?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:06","pubTimestamp":1780398360,"startTime":"0","endTime":"0","summary":"Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a federal court in California, stoking renewed uncertainty around the company's attempt to contain litigation risk this year.Shares in the German agricultural-and-pharmaceutical group were down 5% in European midday trading, taking their year-to-date loss to nearly 10%.Bayer said it plans to oppose a conditional order from the Judicial Panel on Multidistrict Litigation regarding the proper venue for the settlement. The company in February proposed the settlement to resolve current and future claims alleging its Roundup product causes cancer, with payments made over two decades but front-loaded to this year.\"We are confident in our arguments that the class settlement case should be remanded to Missouri State Court,\" a Bayer spokesman said.The move comes two days before a deadline for plaintiffs to opt out of the settlement, which the company considers still valid.The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639986640","title":"Bayer's Key Pharma Products Face Competitive Risk -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2639986640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639986640?lang=en_us&edition=fundamental","pubTime":"2026-05-29 16:15","pubTimestamp":1780042500,"startTime":"0","endTime":"0","summary":"0815 GMT - Bayer's pharmaceutical business has good momentum but faces risks over the medium term from potential competition to key products like its Kerendia kidney drug and asundexian for stroke prevention, Jefferies analysts say. The German group's pharma division should deliver annual sales growth of 2% over the 2025-2030 period, compared with the average growth rate of 5% among peers, according to Jefferies. Asundexian's potential market is a lot smaller after a trial for a type of heart arrhythmia known as atrial fibrillation failed and Bristol Myers Squibb's rival treatment milvexian could have an edge, they add. For Bayer's Kerendia, momentum is good for now, but the threat of competition looms on the horizon with AstraZeneca and Mineralys Therapeutics developing a new class of drugs, Jefferies says. Bayer shares fall 1.3%. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU1571399168.USD","LU2237443895.HKD","LU0432979614.USD","LU1670710661.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1323610961.USD","MLYS","LU2462157665.USD","LU1670710588.SGD","LU2456880835.USD","LU1868836757.USD","BK4007","LU1989771016.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1585245621.USD","LU2242646821.SGD","LU2125154778.USD","LU2237443382.USD","LU1074936037.SGD","LU1430594728.SGD","BK4532","LU0225771236.USD","BMY","BK4139","LU0306806265.USD","LU0058720904.USD","LU1829250122.USD","LU0456855351.SGD","LU0289739699.SGD","IE00BFXG1179.USD","LU1670711123.USD","IE00B2B36J28.USD","LU1718418525.SGD","AZNH","BK4568","IE0009355771.USD","LU1868837300.USD","LU0061475181.USD","LU2125154935.USD","LU0882574055.USD","LU2237443622.USD","LU0321505868.SGD","BAYRY","LU1291159041.SGD","AZN","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639647100","title":"Bayer Can Still Take Hit If Litigation Strategy Fails -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2639647100","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639647100?lang=en_us&edition=fundamental","pubTime":"2026-05-29 15:42","pubTimestamp":1780040520,"startTime":"0","endTime":"0","summary":"0741 GMT - Bayer's U.S. legal battles remain the main source of uncertainty looming over its shares, which could take a hit if the company's litigation strategy doesn't go to plan, Jefferies analysts say in a research note. The German agricultural-and-pharmaceutical conglomerate has captured a substantial majority of its litigation risk with an 11.8 billion-euro provision structure, according to Jefferies. That said, an adverse litigation outcome could prompt generalist investors to pivot out of Bayer, the analysts say. \"Bayer may become significantly more investable, but this is not a given.\" Jefferies raises its target price on Bayer stock to 40 euros from 25 euros. Shares fall 0.8% to 37.55 euros. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637914335","title":"Bayer to present new data across oncology portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2637914335","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637914335?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:20","pubTimestamp":1779366045,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that new data from studies across their oncology portfolio will be presented at the upcoming 2026 American Society of Clini...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-to-present-new-data-across-oncology-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-to-present-new-data-across-oncology-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637075381","title":"Bayer announces Priority Review designation for Kerendia","url":"https://stock-news.laohu8.com/highlight/detail?id=2637075381","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637075381?lang=en_us&edition=fundamental","pubTime":"2026-05-21 17:45","pubTimestamp":1779356710,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that the FDA accepted its supplemental new drug application and granted Priority Review designation for Kerendia, which is ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-announces-priority-review-designation-for-kerendia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-announces-priority-review-designation-for-kerendia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4007","BAYRY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636831044","title":"Bayer granted priority review for asundexian by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636831044","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636831044?lang=en_us&edition=fundamental","pubTime":"2026-05-19 17:16","pubTimestamp":1779182185,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that the FDA has accepted the company’s new drug application and granted priority review designation for its investigationa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-granted-priority-review-for-asundexian-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-granted-priority-review-for-asundexian-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BAYRY","BK4007","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635735300","title":"Bayer launches 2026 campaign to expand food access with Luke Bryan","url":"https://stock-news.laohu8.com/highlight/detail?id=2635735300","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635735300?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:27","pubTimestamp":1778682455,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) and country superstar and five-time Entertainer of the Year Luke Bryan today launched their 2026 campaign to expand access to food an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-launches-2026-campaign-to-expand-food-access-with-luke-bryan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-launches-2026-campaign-to-expand-food-access-with-luke-bryan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634121464","title":"Dow Jones Top Company Headlines at 9 AM ET: EBay Rejects GameStop's $56 Billion Takeover Proposal | Under ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2634121464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634121464?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:00","pubTimestamp":1778590800,"startTime":"0","endTime":"0","summary":"The e-commerce platform called the offer \"neither credible nor attractive\" after a rollout by GameStop CEO Ryan Cohen appeared to fizzle.Under Armour reported a fiscal fourth-quarter loss as revenue declines in North America offset international sales gains.JD.com returned to profit with better-than-expected results in the first quarter, as the Chinese e-commerce giant made progress in stemming losses in its food-delivery business.Bristol-Myers Squibb and China's Hengrui Pharma Forge Tie-Up. U.S. pharma giant Bristol-Myers Squibb has struck a partnership and licensing deal with Chinese drugmaker Hengrui, in a deal that could worth more than $15 billion.EU's Von der Leyen Floats Tighter Restrictions for Minors' Social Media Use. The European Union could present new rules to tighten restrictions on minors' use of social media platforms this summer.Nvidia Stock Drops After Report CEO Huang Is Excluded From Trump's China Trip. Sam Altman's Business Dealings Under GOP Scrutiny Ahead of Open","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ18W456.USD","600276","GMEY","BAYRY","JD","NVO","BK4076","UAA","IE00BZ18W340.USD","IGME","BK4577","BK4547","01024","EBAY","TCEHY","GME","00700","ADNOC.AU","NVDA","GMEU","BK4144","DJIA","09618","BK4590","BK4585","BK4561","01276","BK4581","RGTI","BZFD","BMY","BK4588","IE00BMQBXF63.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634009216","title":"Stocks to Watch: GameStop, Venture Global, Wendy's, Hims & Hers -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2634009216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634009216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:05","pubTimestamp":1778587500,"startTime":"0","endTime":"0","summary":"GameStop : The board of eBay rejected an unsolicited $56 billion bid from the videogame retailer; its shares slid premarket.Wendy's : The stock surged premarket after the Financial Times reported that Nelson Peltz's Trian Fund Management is in talks to raisen funds for a bid to take the hamburger chain private.Venture Global : Shares of the liquefied-natural-gas exporter rose 9% in premarket trading after it reported a sharp increase in first-quarter revenue and profit.Hims & Hers : The telehealth platform's stock dropped 15% premarket after it said its move to rejigger its weight-loss offerings drove up costs.Under Armour : Shares in the sportswear brand dropped more than 11% in premarket after it reported a fall in quarterly revenue.This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL .","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMEY","HIMY","BK4077","BK4196","BAYRY","IE00BZ1G4Q59.USD","HMYY","IE00BKVL7J92.USD","NVO","BK4007","LU0154236417.USD","BK4076","GPRO","BK4209","BK4202","IGME","BK4577","LU1093756325.SGD","BK4547","BK4599","UA","HIYY","HIMS","GME","BK4023","GMEU","BK4213","NVOH","BK4078","BK4585","VG","WEN","LU1093756168.USD","NVOX","HIMZ","GTM","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213508","title":"Bayer Shares Climb After Earnings Beat Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213508","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213508?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:09","pubTimestamp":1778584140,"startTime":"0","endTime":"0","summary":"Bayer shares jumped after the German agricultural-and-pharmaceutical group reported first-quarter adjusted earnings that exceeded analysts' expectations mainly thanks to a strong performance at its agricultural division.Shares in Bayer rose as much as 6.9% in European morning trading Tuesday, in a session with broad-based losses across European stocks due to worries about the Middle East conflict.The company said first-quarter earnings before interest, taxes, depreciation and amortization excluding special items rose 9% to 4.45 billion euros , with growth in its agricultural division offsetting declines in pharma and consumer health. Analysts expected the metric at 3.93 billion euros, according to consensus estimates compiled by Vara Research.The results come as Bayer awaits the outcome of Chief Executive Bill Anderson's efforts to contain litigation over its Roundup weedkiller this year, after longrunning legal battles made the company book multibillion-dollar provisions and weighed o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291180","title":"Stocks to Watch: Venture Global, Hims & Hers, GoPro -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291180","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634291180?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:08","pubTimestamp":1778576880,"startTime":"0","endTime":"0","summary":"Venture Global : The liquefied-natural-gas exporter, which stands to benefit from the closure of the Strait of Hormuz, is due to report results this morning, potentially shedding light on the strength of demand. Shares rose premarket.Hims & Hers : The telehealth platform's stock slid more than 15% premarket after it said its move to rejigger its weight-loss offerings drove up costs.Under Armour On Holding : The sportswear brand is due to post results today.Novo Nordisk : The company said some patients on a higher-dose Wegovy shot lost 27.7% of their body weight on average in a trial. Shares rose in European trade.Zoominfo Technologies : Shares in the market-intelligence company plummeted after it cut its full-year guidance late Monday.This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL .","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","BK4077","BK4196","BAYRY","IE00BZ1G4Q59.USD","LU0057025933.USD","HMYY","IE00BKVL7J92.USD","LU0069063385.USD","BK4007","LU0154236417.USD","NVO","GPRO","BK4202","LU1093756325.SGD","BK4146","BK4547","BK4599","LU0289961442.SGD","HIYY","HIMS","ONON","UA","LU0511384066.AUD","LU1804176565.USD","LU0472753341.HKD","BK4023","LU0289739343.SGD","BK4213","NVOH","BK4078","BK4585","VG","LU1093756168.USD","NVOX","HIMZ","LU2265009873.SGD","GTM","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634298704","title":"European Indexes Drop as Middle East Tensions Look Set to Continue -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2634298704","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634298704?lang=en_us&edition=fundamental","pubTime":"2026-05-12 15:25","pubTimestamp":1778570700,"startTime":"0","endTime":"0","summary":"0725 GMT - European indexes fell in opening trade as the impasse in the Middle East looks set to continue after President Trump said the cease-fire with Iran was on life support. The Europe-wide Stoxx 600 index was down 1% after closing higher in the previous session. All sectors are down with financials leading the falls--down 1.5%. U.K. testing specialist Intertek's shares are leading the risers--up 4.8%--after Swedish buyout group EQT sweetened its takeover bid. Bayer shares are also up after reporting higher earnings. London's FTSE 100-index was down 1%, while Germany's DAX and France's CAC were down 1.1% and 0.8%, respectively. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPV","BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634676322","title":"Bayer Q1 Adj. EPS $0.79 Beats $0.64 Estimate, Sales $15.697B Beat $15.490B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634676322","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634676322?lang=en_us&edition=fundamental","pubTime":"2026-05-12 14:39","pubTimestamp":1778567962,"startTime":"0","endTime":"0","summary":"Bayer (OTC:BAYRY) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.64 by 23.44 percent. This is a 21.54 percent increase over earnings of $0.65 per share from the same period","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52476108/bayer-q1-adj-eps-0-79-beats-0-64-estimate-sales-15-697b-beat-15-490b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181962","title":"Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633181962?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:36","pubTimestamp":1778063760,"startTime":"0","endTime":"0","summary":"Bayer said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma treatment in the company's biggest deal in years.The German pharmaceutical-and-agricultural group said Wednesday that the acquisition of San Francisco-based Perfuse would complement its drug pipeline and leverage its ophthalmology footprint. Eye drug Eylea was the top-selling product at Bayer's pharma business last year, but the medicine is now facing pricing pressures after it went off patent.Perfuse's lead drug candidate is an experimental treatment for glaucoma and diabetic retinopathy currently being tested in mid-stage clinical trials, Bayer said. It has the potential to become one of the first disease-modifying treatments for both conditions, the company added.Bayer said it would pay $300 million upfront, with the rest of the price subject to hitting development, regulatory, and commercial targets.Perfuse is Bayer's biggest acquisiti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","BAYRY","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633186315","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2633186315","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633186315?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:02","pubTimestamp":1778061774,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsMay 6 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:** Stack Infrastructure, a data centre firm ow","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL6N41J0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","IE00BN29S564.USD","IE0004445015.USD","LU2125154778.USD","LU1564329461.SGD","LU0985489474.SGD","LU0127658192.USD","LU2322448957.HKD","LU2023250843.SGD","LU2403377893.USD","LU1674673691.USD","LU1839511570.USD","LU2133065610.SGD","LU1642822529.SGD","IE00B7SZLL34.SGD","LU0154236417.USD","LU0096364046.USD","SG9999015952.SGD","LU0109391861.USD","IE0009356076.USD","LU2236285917.USD","IE000YTNTUN2.SGD","LU0528227936.USD","IE00B3SWFQ91.USD","LU0174119429.USD","LU0648000940.SGD","LU0082616367.USD","LU0077335932.USD","IE00B5949003.HKD","LU1823568750.SGD","LU1145028129.USD","IE00BK4W5M84.HKD","LU0320765489.SGD","LU2168564149.EUR","LU2347655156.SGD","LU0553294199.USD","LU1046421795.USD","IE000KEQY171.SGD","LU1670711123.USD","LU0053666078.USD","LU0985320562.USD","IE00B19Z8W00.USD","LU0061474960.USD","LU2361044949.HKD","LU0006306889.USD","LU0345769128.USD","LU2247934214.USD","LU2054465674.USD","SGXZ31699556.SGD","LU1127390331.HKD","IE00BJJMRY28.SGD","LU1868837300.USD","LU2456880835.USD","BK4135","LU1992135472.HKD","LU2065170008.USD","LU0097036916.USD","LU1992135399.USD","LU1301847155.USD","LU2462157665.USD","IE00BJTD4V19.USD","LU1366333091.USD","CRBG","IE00BK4W5L77.USD","LU1718418525.SGD","LU0210528500.USD","LU2317271919.USD","LU0310799852.SGD","SGXZ23171101.USD","LU2360106780.USD","LU2097829019.USD","LU0265550946.USD","LU0149725797.USD","LU0690374961.EUR","AIG","SG9999017495.SGD","LU0823434583.USD","LU1674673428.USD","LU0106261372.USD","IE00BQXX3F31.USD","LU0208291251.USD","LU1489326972.SGD","LU1548497426.USD","LU0080751232.USD","LU1670711040.USD","LU2404859667.USD","LU2272731600.USD","LU0011850046.USD","IE00B1BXHZ80.USD","LU0889565833.HKD","IE00BLSP4452.SGD","LU0215105999.USD","DGT.AU","LU0072462426.USD","LU1429558221.USD","LU1720051108.HKD","LU0980610538.SGD","LU0823434740.USD","SG9999018857.SGD","LU1366192091.USD","LU2430703095.HKD","LU0211328371.USD","LU0433182093.SGD","LU0784385170.HKD","SGXZ51526630.SGD","LU0256863902.USD","LU0552385451.USD","IE00BKDWB100.SGD","LU0640476718.USD","IE00BQXX3D17.EUR","IE00BFSS8Q28.SGD","LU0882574139.USD","LU0795875169.SGD","LU1974910355.USD","LU1791710582.SGD","LU2746668461.USD","LU1551013342.USD","LU1201861249.SGD","LU2357305700.SGD","LU1868836914.USD","LU1861558580.USD","LU1242518857.USD","LU0417517546.SGD","LU1852331112.SGD","LU2764262908.HKD","LU2487616109.SGD","BAYRY","LU0203345920.USD","IE000ITXATA3.USD","LU2430703251.USD","BK4543","LU0354030438.USD","LU0170899867.USD","LU0444973449.USD","LU1069344957.HKD","LU1732800096.USD","LU0320765059.SGD","HK0000304805.HKD","SG9999015945.SGD","LU2746668974.SGD","LU0070302665.USD","LU0648001328.SGD","LU1280957306.USD","LU1201861165.SGD","LU0354030511.USD","LU1496350502.SGD","LU0878866978.SGD","LU1242518931.SGD","LU0267386448.USD","LU0820561818.USD","LU0308772762.SGD","LU2087621335.USD","LU2264538146.SGD","LU0276348264.USD","LU2272731865.HKD","LU2505996509.AUD","LU2552382058.USD","LU0109392836.USD","LU0689472784.USD","LU1035775433.USD","LU1551013425.SGD","LU0198837287.USD","LU1074936037.SGD","LU1316542783.SGD","LU1699723380.USD","IE0005OL40V9.USD","GB00B4QBRK32.GBP","LU0225283273.USD","BK4184","LU0323591593.USD","LU1232071149.USD","LU2065169927.USD","LU2896262040.SGD","LU0211331839.USD","LU1914381329.SGD","LU2552382132.HKD","BK4524","LU2322448791.USD","IE00BLSP4239.USD","LU2065171311.SGD","IE00B4JS1V06.HKD","LU2505996681.GBP","BK4592","LU0820562030.AUD","LU2458330243.SGD","LU0353189763.USD","LU0133085943.USD","IE00BJJMRX11.SGD","LU1629891620.HKD","BK4077","LU0234570918.USD","LU1564329032.USD","BK7090","LU0708995401.HKD","LU1435385759.SGD","LU2543165471.USD","OWL","IE00BN8TJ469.HKD","LU1732799900.SGD","BK4585","HK0000914660.USD","LU0724617625.USD","SG9999001077.SGD","LU0795875086.SGD","LU1868836757.USD","IE00BJLML261.HKD","LU1066051498.USD","LU2168564495.EUR","LU2125154935.USD","LU2168564222.USD","LU0265550359.USD","IE0034235303.USD","LU1861559042.SGD","LU1988902786.USD","LU1261432733.SGD","ALX.AU","LU0061475181.USD","LU2602419157.SGD","LU1814569148.SGD","LU2347655073.USD","LU0642271901.SGD","IE0009G5SDU7.USD","LU0683600562.USD","IE0004445239.USD","LU0061474705.USD","LU0056508442.USD","LU1064131342.USD","LU1670628061.USD","IE0002270589.USD","LU1267930490.SGD","IE00B775H168.HKD","LU0256863811.USD","LU1868836591.USD","LU2168564065.EUR","LU0130518102.USD","LU0348723411.USD","BK4588","LU1815336760.USD","IE00B19Z9505.USD","IE00B19Z8X17.USD","LU2756315318.SGD","IE00BMPRXR70.SGD","LU2473716301.USD","IE0003U64NQ7.SGD","LU0466842654.USD","SGXZ81514606.USD","LU1564329115.USD","LU2756315664.SGD","LU0949170772.SGD","LU1116320737.USD","LU2420271590.USD","LU0823421333.USD","LU0345769631.USD","LU1571399168.USD","LU1235294995.USD","SG9999015986.USD","LU0545039389.USD","LU0203202063.USD","IE00BMPRXQ63.HKD","LU0314104364.USD","LU2250418816.HKD","SG9999004303.SGD","LU0949170426.SGD","LU0957791311.USD","LU0964807845.USD","SG9999014898.SGD","SG9999015978.USD","LU0130102774.USD","LU0661504455.SGD","IE00BMPRXN33.USD","GB00B4LPDJ14.GBP","LU2552382215.SGD","LU0787776722.HKD","BK7166","LU1803068979.SGD","LU0211327993.USD","LU1066053197.SGD","LU2361045086.USD","LU2326559502.SGD","LU1720051017.SGD","LU1670627923.USD","LU2168563687.JPY","LU1084165304.USD","LU0079474960.USD","LU0979878070.USD","LU2237957811.SGD","IE00BFSS7M15.SGD","LU0210536198.USD","LU2272731782.SGD","LU0210533765.USD","SG9999002232.USD","HK0000304797.USD","LU0943347566.SGD","LU1804176565.USD","LU0820561909.HKD","LU1868837136.USD","IE00B1XK9C88.USD","LU1564329628.SGD","IE0034235188.USD","LU2417539215.USD","LU2361044865.SGD","LU1670710661.SGD","IE00B7KXQ091.USD","LU2381873111.SGD","IE00BWXC8680.SGD","LU1697837992.HKD","LU2065171402.SGD","LU1153585028.USD","LU0912757837.SGD","LU0726765562.USD","LU2764263039.SGD","LU0070217475.USD","IE00BBT3K403.USD","LU2237957902.USD","LU2458330169.SGD","LU0203201768.USD","LU2764263203.CNY","LU2462591350.SGD","IE00BJTD4N35.SGD","SGXZ99366536.SGD","SG9999014914.USD","IE00BQXX3C00.GBP","LU0068578508.USD","HK0000914686.HKD","LU1815333072.USD","LU0477156797.USD","LU2242650005.HKD","LU0738911758.USD","LU0096362180.USD","LU2023250330.USD","LU1267930730.SGD","IE000W1ABFV2.USD","LU1791710400.SGD","SG9999002224.SGD","LU0203347892.USD","LU0784384876.USD","IE00B4YYXB79.USD","LU0784383803.USD","IE00B19Z3B42.SGD","LU2860962120.EUR","LU2265009873.SGD","LU0476273544.USD","LU2087625088.SGD","LU2463028550.USD","LU0157215616.USD","LU0444971666.USD","LU0719512351.SGD","LU2404859741.USD","IE00B19Z3581.USD","LU2063271972.USD","LU0823421416.USD","LU2461242641.AUD","LU2106854487.HKD","LU0130103400.USD","LU2592432038.USD","LU0234572021.USD","LU2360032135.SGD","LU1778281490.HKD","SG9999014880.SGD","LU0788109477.HKD","SG9999018865.SGD","LU2430703178.SGD","LU0353189680.USD","BK4507","LU1116320901.HKD","LU2213496289.HKD","IE0001KFT4U8.USD","SG9999014906.USD","BK4587","LU1119994496.HKD","LU0690374615.EUR","LU0316494557.USD","LU0957808578.USD","LU1670710588.SGD","LU2023250504.SGD","LU1003077747.HKD","LU0786609619.USD","LU2720916845.USD","LU1917777945.USD","LU0784385840.USD","LU0672654240.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110956615","title":"Earning Preview: Bayer A.G. this quarter’s revenue is expected to increase by 1.68%, and institutional views are mixed with a cautious tilt","url":"https://stock-news.laohu8.com/highlight/detail?id=1110956615","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110956615?lang=en_us&edition=fundamental","pubTime":"2026-05-06 03:40","pubTimestamp":1778010010,"startTime":"0","endTime":"0","summary":"Abstract Bayer A.G. will release its quarterly results on May 12, 2026 before-market; this preview outlines consensus revenue, margin, EBIT, and EPS expectations, reviews last quarter’s performance,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Bayer A.G. this quarter’s revenue is expected to increase by 1.68%, and institutional views are mixed with a cautious tilt","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631598136","title":"Bayer upgraded to Buy from Neutral at Rothschild & Co Redburn","url":"https://stock-news.laohu8.com/highlight/detail?id=2631598136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631598136?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:00","pubTimestamp":1777453233,"startTime":"0","endTime":"0","summary":"Rothschild & Co Redburn upgraded Bayer (BAYRY) to Buy from Neutral with a EUR 56 price target Published first on TheFly – the ultimate source for r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-upgraded-to-buy-from-neutral-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-upgraded-to-buy-from-neutral-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":89,"code":"91000000","status":"200"}]}}